Laird Norton Tyee Trust »

Takeda Pharmaceutical shares owned by Laird Norton Tyee Trust

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Laird Norton Tyee Trust from 13F filings

Historical chart of Laird Norton Tyee Trust investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Laird Norton Tyee Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Laird Norton Tyee Trust

Quarter filed Position value Share count Share price at filing
2025-12-31 $783k 50k 15.59

More positions owned by Laird Norton Tyee Trust

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Laird Norton Tyee Trust

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
FMR
UBS Group
Brandes Investment Partners
Toronto-Dominion Bank
BlackRock
Millennium Management
Renaissance Technologies
First Trust Advisors
Van Eck Associates Corp.
Northern Trust
Citadel Advisors
Managed Asset Portfolios

View all funds holding Takeda Pharmaceutical